Stock Market Today, March: Grab's Buyback and Foodpanda Bet
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Ways To Monetize Simple Activities At Home
Discover ways to monetize simple activities at home. Start earning extra income doing what you enjoy and have fun!
19,288 articles
Amazon Andy Jassy Just Bets $200B on AI Era, Here’s How
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
Price Prediction: Intel Stock Outlook Turns Cautious Amid Rally
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
Palantir Technologies Just Created Momentum: Outlook
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
Surgical Robotics Meets Intuitive: AI Boosts MedTech Stocks
AI-enabled surgical robotics are turning hospitals into data hubs. Intuitive Surgical, Medtronic, and Stryker sit at ...
NVIDIA Says “Physical Here” Reshapes Blue-Collar Jobs
NVIDIA confirms a booming Physical AI segment, surpassing $6 billion in annual revenue as robots move from labs to wa...
AI IPO Frenzy Sparks a Pressure Cooker Ready Market
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Modine (MOD) 2026 Earnings Outlook for Investors: Key Trends
Investors are watching Modine for clues on growth in HVAC and thermal solutions. This guide breaks down the modine (m...
Okta (OKTA) 2027 Earnings: Growth Outlook and Risks
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...
Live: Will HIVE Smash Q4 Earnings Tonight After Rally
As HIVE Digital Technologies prepares to report Q4 results, the stock has surged more than 100% in May. Traders are w...
Lululemon Athletica After Latest Earnings: Buy or Not
Lululemon faces a pivotal moment after its latest earnings. This analysis breaks down what's working, what's slowing,...
Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status